With its latest acquisition, One Drop looks to integrate Sano Intelligence's CGM wearable for broader health monitoring

One Drop recently announced the acquisition of Sano's assets, IP and a portion of its staff.
By Dave Muoio
03:03 pm
Share

Digital diabetes-management company One Drop announced last week that it has acquired the assets, IP and certain staff of Sano Intelligence, the maker of a non-invasive connected CGM patch. The terms of this asset purchase were not disclosed.

Sano was founded in 2011, and over the course of the decade raised approximately $20 million from investors such as Fitbit, Intel Capital, True Ventures and Rock Health.

The initial game plan for its sensor platform was continuous monitoring of metabolic panel data for patients, providers and those with chronic illnesses. However, the company planned to market its blood glucose wearable to consumers as a wellness product, rather than to help patients manage their diabetes.

WHAT'S THE IMPACT?

One Drop, which primarily sells a wireless blood glucose monitor system and data-driven self-management app, said that its goal was to acquire and integrate Sano's technology and years of research into its own offerings. The company highlighted Sano's silicon-sensing product infrastructure, which it aims to incorporate into "a painless, silicon-based continuous health sensing platform for use across multiple conditions," according to the announcement.

"Telehealth and digital self-management of chronic conditions are more important than ever, and the benefits of real-time health sensing are obvious," Jeff Dachis, One Drop CEO and founder, said in a statement. "By introducing continuous health sensing technology to One Drop's personalized solutions for a rapidly growing variety of health issues, we can empower people to make informed, proactive choices and prevent problems before they happen."

In addition to Type 1 and Type 2 diabetes management, One Drop's platform currently provide support to patients with gestational diabetes, prediabetes, high blood pressure and high cholesterol.

THE LARGER TREND

One Drop's disease-management offering has been pushing into the consumer market as of late.

The company found a powerful friend in Apple last year, having integrated its platform with Apple's Health Records, and, shortly after offering its blood glucose monitoring system, being sold in Apple's brick-and-mortar storefronts. One Drop's offering has since hit Walmart store shelves as well.